Cargando…
Influenza neuraminidase
Please cite this paper as: Air. (2012) Influenza neuraminidase. Influenza and Other Respiratory Viruses 6(4), 245–256. Influenza neuraminidase is the target of two licensed antivirals that have been very successful, with several more in development. However, neuraminidase has been largely ignored as...
Autor principal: | Air, Gillian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290697/ https://www.ncbi.nlm.nih.gov/pubmed/22085243 http://dx.doi.org/10.1111/j.1750-2659.2011.00304.x |
Ejemplares similares
-
Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses
por: Gulati, Shelly, et al.
Publicado: (2009) -
Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6
por: Venkatramani, Lalitha, et al.
Publicado: (2012) -
Influenza Virus Neuraminidase: Structure and Function
por: Shtyrya, Y.A., et al.
Publicado: (2009) -
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019) -
Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)